ウブレチド®錠によるコリン作動性クリーゼの防止を目的とした医薬品情報提供とその評価

概要

論文の詳細を見る
We evaluated the effectiveness of preventing cholinergic crisis due to Ubretid tablets using a notice in electronic medical records concerning the initial dosage and the correct timing for increasing the dose.We also conducted a survey to investigate doctors'knowledge of the Ubretid tablet and opinions of the method used for displaying the notice in electronic medical records.Displaying the notice resulted in a 4-fold increase in prescriptions with the proper initial dosage though there was no change in prescriptions giving the correct timing for increasing the dosage.Overall,there was a nine-fold increase in proper prescriptions giving the correct initial dosage and correct timing for increasing the dose.The survey of doctors revealed that they had little knowledge of Ubretid tablets and therefore considered the use of a notice in electronic medical records to be a very useful.These results suggested that displaying such a notice in electronic medical records could be a useful and an easy way of preventing cholinergic crisis due to Ubretid tablets.
日本医療薬学会の論文